Q32 Bio Inc.
NASDAQ: QTTB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jodie Pope Morrison
- Employees
- 28
- Headquarters
- Waltham, United States
- IPO year
- 2018
- Market cap
- $142.6M
- Website
- https://www.q32bio.com
Loading QTTB…
Loading profile data…Frequently asked questions about QTTB
What does Q32 Bio Inc. (QTTB) do?
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX...
Where does QTTB trade?
Q32 Bio Inc. (QTTB) trades on the NASDAQ Global Market.
What sector is QTTB in?
Q32 Bio Inc. (QTTB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Q32 Bio Inc.?
Jodie Pope Morrison is the chief executive officer of Q32 Bio Inc. (QTTB).
Where is Q32 Bio Inc. headquartered?
Q32 Bio Inc. is headquartered in United States.
Does QTTB pay a dividend?
Q32 Bio Inc. (QTTB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QTTB go public?
Q32 Bio Inc. (QTTB) completed its initial public offering in 2018.